AHRI Data Repository
Data Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / TASP / ANRS12249TASP / variable [V4263]
tasp

Treatment as Prevention ANRS 12249

South Africa, 2012 - 2016
Get Microdata
Reference ID
ANRS12249TasP
Producer(s)
Dabis, François, Newell, Marie-Louise, Pillay, Deenan
Collections
TasP ANRS 12249
Metadata
Documentation in PDF DDI/XML JSON
Created on
Jan 30, 2018
Last modified
Jan 30, 2018
Page views
394627
Downloads
4610
  • Study Description
  • Data Dictionary
  • Downloads
  • Get Microdata
  • Related Publications
  • Data files
  • HIV Drug
    Treatments
  • Households
  • CHEs
  • Lab Test
    Results
  • ARTemis Lab
    Results
  • ARTemis
    Patients
  • CHE Adverse
    Events
  • SCBs SCCs
  • CHE Action
    Plans
  • Clusters
  • Visits
  • HHIs
  • CFUs
  • CFU Pill Tests
  • Local Areas
  • Census Rounds
  • SCIs
  • Individual
    Consents
  • SAEs Initial
    Notifications
  • SAEs Initial
    Notifications -
    Events details
  • SAEs Initial
    Notifications -
    Medications
  • SAEs
    Complementary
    Notifications
  • SAEs
    Complementary
    Notifications -
    Medications
  • CBCs
  • Specimens
  • IQs
  • Minority
    Variants
  • BMQ Surveys
  • NGS Genomics
  • Refusals
  • NgsAssembQuality
  • Sample Genomics
  • Locations
  • LinkToCareTracker
  • Exits
  • ACCDB
    Encounters
  • ACCDB Encounter
    Therapies
  • Individuals
  • Trial Statuses
  • DBS results

According to the physician, is this SAE related to any causes other than the research? If yes, describe (SAECausedByOtherDesc)

Data file: SAEs Complementary Notifications

Overview

Valid: 101
Type: Discrete
Width: 244
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
2016/03/17 1
1%
Abdominal TB 1
1%
Abnormal LFT's present at baseline. 1
1%
Abnormality presental baseline but has gotten worse 1
1%
Acuretic therapy for congestive cardiac failure resulting in hypernatremia and acute renal failure. 1
1%
Acute Gastroenteriitis 1
1%
Acute gastro enterijtis resulting in Pre renal failure exacerbated by zencfair. Patient not fully treated in death. 1
1%
Acute gastroentents Pulmonary TB 1
1%
Advance HIV desease. 1
1%
Anaemia of chronic decease 1
1%
Anaemia secondary to menorrhagia 1
1%
Bacterial meningitis 1
1%
Cause of renal failure was drug TDF, he was on this prior to inclusion in the study 1
1%
Drug induced liver injury from TB 1
1%
Due to multiples PTB. Post TB bronchrectesis can be an expected complication. 1
1%
First frimester miscarriages are very common 1
1%
Gallstones were found to be the cause of the patient condition. She jis well post opetration. 1
1%
Hypertensive/ccf/ chronic renal failure 1
1%
Hypokalaemic cardial arrest. 2 Arrythmia hypokalatmia no Diuretic therapy. 1
1%
Immunocompromised , so at risk of abscess. 1
1%
Immunosupressed patient sugestable to meningitis 1
1%
Initially on TDF/3TC/EFV from 10/08/2012 before switching to Atripla on 08/05/2013 1
1%
Joined the trial already on TDF/FTC/EFV 1
1%
MDR-TB 1
1%
Menorrhagia causing iron deficiency anaemia. 1
1%
Missing 18
17.8%
Orolabial herpes simplex 1
1%
Participant PRE-ART therefore sugectable to TB MDR - TB highly prevalant in subdiscrict. 1
1%
Participant ages + immune status are risk factor for cancer. 1
1%
Participant clinically very ill. With low CD4 and malnutrition - highly suspectible to Tubercolosis. 1
1%
Participant defaulted his anti convulsants & therefore at risk of siecures 1
1%
Participant died due to severe diarrhoea following herbal enema. She was still awaiting ultrsound to determine cause of elevated liver enzymes. 1
1%
Participant had TB symptoms at baseline 1
1%
Participant had longstanding history of abnormal bleeding. Recurrance of same problem, cause still being investigated. 1
1%
Participant with stage IV HIV, also has underlying malnutritious, he is highly suscptible to opportunistic infection 1
1%
Participant with treatment failure immunosuppresion may pre-dispose her to malnutrition. 1
1%
Participants with co-marbid HIV & TB Having revurrent TB due to poor immunity. 1
1%
Patient entered Tasp with renal impliment 1
1%
Patient had been lost to follow up for 9 months + defaulted ART before returning already very sick. 1
1%
Patient had pulmonary TB + puncytopenia, Continued to deteriorate after stopping AZT. 1
1%
Patient has been diagnosed with idiopathic Thrombocytopanic Purpura (Cause unknown) 1
1%
Patient immnocompromised at risk of MDR TB 1
1%
Patient is a defaulter and ART and HCTZ. He is currently on neither. His renal failure was discovered at baseline, so unlikely due to participation in Tasp. 1
1%
Patient was already on ART PRIOR TO JOINING Tasp. 1
1%
Patient was assaulted 1
1%
Patient was diabetes, hypertension and HIV which all could result in renal failure 1
1%
Patient was immunocorpromised +at risk of opportunistic intrection regaless of participant in this trial. 1
1%
Patient was lost to following up + severely immunosupressed 1
1%
Patient with advanced dissease a nd severe immunosupptrssion 1
1%
Patient with co-morbid HIV and TB not improving with treatment, suspected resistance TB 1
1%
Patient with declining CD4 count + malnutrition 1
1%
Patient with very law CD4 count, susceptible to oppotunistics infection 1
1%
Pervic mass , requires further investigation 1
1%
Physical assault 1
1%
Poorly controlled BP leading to stroke . 1
1%
Pre-renal failure from Acute gastroenteritis may have been exacerbated by tenofovir + hydrochochlord thiazide. 1
1%
Presumptive Pulmonary Tuberculosis 1
1%
Probable Pulmonary Tb - Not culture proven . 1
1%
Probable pulmonary tubercolosis 1
1%
Psychosis may be due to diseminated tubecolosis 1
1%
Pt severely ill with co morbid Mor-TB and advanced HIV disease. She has pur social circumtance and poor nutrition 1
1%
Pulmonary TB 2
2%
Pulmonary Tb Advanced HIV Infection 1
1%
Pulmonary tuberculosis 1
1%
Putient at risk of ITP regadless of participant in resech 1
1%
Renal failure was present at baseline. The patient is immunocompromised with high rish of oppotunist infection. 1
1%
See intiel SAE notification 1
1%
Short duration of psychosis supports brief psychotic disorder. Patient now on TDF/3TC/Efv-no recurrence of symptoms 1
1%
Shortness of breath,probably had some respiratory problem. 1
1%
Stabbed abdomen 1
1%
Stroke due to poor controlled BP - Poor compliance 1
1%
TB dicease 1
1%
The patient has renal failure at baseline entry into the trial. The cave of renal failure news to be investigated further. 1
1%
The patient is Immunocompromised and at risk of gastronentetris (which caused dehydration + subsequent renal impaired) 1
1%
The patient is very immunocompromised and at risk of opportunistic infections 1
1%
The patient suffered gastroentertis, which canned renal failure. After rehydration she now has grade 2 hypercreatinineamia 1
1%
The patient was at risk of anaemia + renal failure regardless of participation in research. 1
1%
The patient was at risk of opportunistic infection due to HIV 1
1%
The patient was severely immunocompromised and malnourished 1
1%
The putrent is immunocompromised high rish of opportunist infections. 1
1%
This appears to be long -studying confussion prior to entry to Tasp. He has now been transfer back to government health care 1
1%
This patient was severely immunocompromised 1
1%
idiopathic htrombocytopaemic purpura ,abnormal blood results predated enrollment trial. 1
1%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
AHRI Data Repository

© AHRI Data Repository, All Rights Reserved.